B MOGEN BIOTECHNOLOGIES INC has a total of 16 patent applications. It decreased the IP activity by 71.0%. Its first patent ever was published in 2017. It filed its patents most often in United States, Australia and Canada. Its main competitors in its focus markets biotechnology, pharmaceuticals and foods and drinks are KSQ THERAPEUTICS INC, EXUMA BIOTECH CORP and SHANGHAI UNICAR THERAPY BIO MEDICINE TECH CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | Australia | 2 | |
#3 | Canada | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 | |
#6 | China | 1 | |
#7 | Israel | 1 | |
#8 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Enzymes | |
#4 | Peptides | |
#5 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Webber Beau | 15 |
#2 | Kumar Sandeep | 15 |
#3 | Hogdal Leah | 15 |
#4 | Otto Neil | 15 |
#5 | Largaespada David | 15 |
#6 | Moriarity Branden | 15 |
Publication | Filing date | Title |
---|---|---|
AU2019288669A1 | Enhanced hat family transposon-mediated gene transfer and associated compositions, systems, and methods | |
US2020323902A1 | ENHANCED hAT FAMILY TRANSPOSON-MEDIATED GENE TRANSFER AND ASSOCIATED COMPOSITIONS, SYSTEMS, AND METHODS | |
AU2017378482A1 | Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods |